Theresa Pattery is the Vice President, Head of Disease Management Programs at Janssen Pharmaceutica N. V., Research & Development within Global Public Health (Johnson & Johnson), focusing on the development and implementation of innovative, sustainable, integrated healthcare solutions, Biomarkers and Data Science analytics for infectious and communicable diseases, that are significantly impacting resource-limited countries and emerging markets.

Driven by her patient-centric insight, she is working on accessible, affordable, mobile digital health solutions to facilitate quality access to patient care by leveraging simple tools that can strengthen health systems and improve health outcomes. She achieves this by working side-by-side and establishing trusting and transparent partnerships with internal and external stakeholders, institutions, NGOs & funding organizations.

She is a Registered Medical Practitioner specialized with a Doctorate in Viral & Microbial Molecular Genetics from the Free University of Brussels (VUB). Previously, Theresa was part of Janssen Infectious Disease & Vaccines (J&J), within Medical Affairs as the US (CAP, CLIA, NY State & other US State Licenses) & EU-certified Laboratory & Medical Director for the accredited, clinical diagnostic laboratories in infectious diseases, oncology and immunology, for Janssen Pharmaceuticals and external business/pharmaceutical partners. She is a trained & certified CAP (College of American Pathologists) Inspector. In addition, she led the co-development of Idylla™ Ebola virus triage test with Biocartis N.V., that was granted emergency use authorization by US FDA and was the Principal Investigator, who ensured that the Idylla™ Respiratory (IFV-RSV) panel from Janssen received US FDA 510(k) clearance. Her prior clinical experience within hospitals and academia ranges from medical microbiology, microbial pathology and molecular genetics of bacterial and viral infectious diseases.

‍